Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05231954 · ClinicalTrials.gov registry record · NA
Digital Detection of Dementia (D Cubed) Studies: D2
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 5,325
- Enrollment target
NCT05231954 is a NA study that has completed, run by Indiana University. The registered enrollment target is 5,325 participants.
The verdict
NCT05231954, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,325 participants
- Enrollment target
Study Summary
The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.
Interventions
- OTHER Passive Digital Marker for screening for ADRD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,325 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2024-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05231954
The ClinicalTrials.gov registry entry for NCT05231954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Passive Digital Marker for screening for ADRD is the first listed.
NCT05231954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05231954 about?
NCT05231954 is a clinical study titled "Digital Detection of Dementia (D Cubed) Studies: D2". The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.
What is the current status of trial NCT05231954?
This trial is currently completed. It is a NA study. The enrollment target is 5,325 participants. The study started on 2022-07-05. Estimated completion is 2024-07-05.
What interventions are being tested in trial NCT05231954?
The interventions under investigation include: Passive Digital Marker for screening for ADRD (OTHER).
Who is sponsoring clinical trial NCT05231954?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.